# OnCo record siren-biotechnology (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/siren-biotechnology/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "siren-biotechnology" ;
  schema:name "Siren Biotechnology"@en ;
  schema:description "Siren Biotechnology uses a harmless virus to deliver a gene for an immune-signalling protein directly into brain tumours, so the tumour itself makes the immune signal that helps fight it."@en ;
  schema:url <https://onco.cc/companies/siren-biotechnology/>, <https://sirenbiotechnology.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://sirenbiotechnology.com/>, <https://sirenbiotechnology.com/siren-biotechnology-announces-fda-clearance-of-first-ind-advancing-company-to-clinical-stage/>, <https://clinicaltrials.gov/study/NCT07902037> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/cytokine-therapy/> .
